US Patent 10028912 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

U.S. Patents

PharmaCompass Sponsored Ads

Post An Enquiry

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

PharmaCompass Sponsored Ads

Post An Enquiry

evonik-m-2025-09-08

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Xls

CATEGORY PAGE

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2JAZZ PHARMS THERAP

filter Patent Number Reset all filters

2 All

01 210028912

API Patent Reset all filters

2 All

01 2Blank

filter FDF Patent Reset all filters

2 All

01 2Y

filter Expiration Date Reset all filters

2 All

01 22032-10-15

01

JAZZ PHARMS THERAP

CYTARABINE; DAUNORUBICIN

BIOHK2025

Not Confirmed

JAZZ PHARMS THERAP

Country

BIOHK2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-10-15

CYTARABINE; DAUNORUBICIN

US Patent Number : 10028912

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209401

Patent Use Code : U-3149

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-10-15

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

JAZZ PHARMS THERAP

CYTARABINE; DAUNORUBICIN

BIOHK2025

Not Confirmed

JAZZ PHARMS THERAP

Country

BIOHK2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-10-15

CYTARABINE; DAUNORUBICIN

US Patent Number : 10028912

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209401

Patent Use Code : U-3150

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-10-15

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!